Jounce Therapeutics, Inc.
JNCEDelisted May 4, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001640455
Jounce Therapeutics, Inc. was delisted on May 4, 2023; its insiders filed their last Form 4 on May 5, 2023; 84 institutions reported holding it in 13F filings for Q1 2023, worth $64.1M in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in Jounce Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 124
- +9 vs. Q3 2021
- Shares held
- 41.1M
- +4.70M (+12.9%) vs. Q3 2021
- Total value
- $342.9M
- +$72.2M (+26.7%) vs. Q3 2021
- New holders
- 23
- 37 more added
- Sold out
- 14
- 36 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JNCE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 1 | $917.8K |
| Q1 2023 | 84 | $64.1M |
| Q4 2022 | 85 | $39.8M |
| Q3 2022 | 102 | $99.5M |
| Q2 2022 | 102 | $129.3M |
| Q1 2022 | 113 | $287.1M |
| Q4 2021 | 124 | $342.9M |
| Q3 2021 | 115 | $270.6M |
| Q2 2021 | 130 | $244.8M |
| Q1 2021 | 124 | $378.3M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Jounce Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 345,631 | $2.89M | 0.00% | −445,303−56.3% | Reduced |
| Northern Trust Corp | 346,722 | $2.89M | 0.00% | −3,925−1.1% | Reduced |
| Congress Asset Management Co | 381,046 | $3.18M | 0.02% | +1120.0% | Added |
| State Street Corp | 506,758 | $4.23M | 0.00% | +8,773+1.8% | Added |
| Two Sigma Advisers, LP | 525,500 | $4.39M | 0.01% | +149,000+39.6% | Added |
| Ally Bridge Group (NY) LLC | 575,000 | $4.80M | 1.68% | +575,000 | New |
| Geode Capital Management, LLC | 622,876 | $5.20M | 0.00% | +8,446+1.4% | Added |
| Erste Asset Management GmbH | 729,587 | $5.92M | 0.11% | −50,000−6.4% | Reduced |
| Barclays PLC | 718,619 | $6.00M | 0.00% | +678,473+1,690.0% | Added |
| Goldman Sachs Group Inc | 720,445 | $6.02M | 0.00% | +46,519+6.9% | Added |
| Acadian Asset Management LLC | 895,224 | $7.47M | 0.03% | +6,859+0.8% | Added |
| Dimensional Fund Advisors LP | 1,118,701 | $9.34M | 0.00% | +71,156+6.8% | Added |
| TRV GP III, LLC | 1,148,780 | $9.59M | 2.40% | −1,900,000−62.3% | Reduced |
| Logos Global Management LP | 1,350,000 | $11.3M | 1.16% | −650,000−32.5% | Reduced |
| Woodline Partners LP | 1,359,528 | $11.4M | 0.17% | +1,359,528 | New |
| Sofinnova Investments, Inc. | 1,582,777 | $13.2M | 0.85% | +945,430+148.3% | Added |
| Vanguard Group Inc | 1,592,032 | $13.3M | 0.00% | +148,603+10.3% | Added |
| Citadel Advisors LLC | 1,729,036 | $14.4M | 0.02% | +4,785+0.3% | Added |
| BlackRock Inc. | 2,511,036 | $21.0M | 0.00% | −23,815−0.9% | Reduced |
| TRV GP II, LLC | 2,697,829 | $22.5M | 93.16% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 2,859,900 | $23.9M | 0.31% | +204,300+7.7% | Added |
| RTW Investments, LP | 2,863,198 | $23.9M | 0.35% | +1,466,995+105.1% | Added |
| PFM Health Sciences, LP | 3,972,868 | $33.2M | 1.16% | +124,046+3.2% | Added |
| Deep Track Capital, LP | 4,000,000 | $33.4M | 2.47% | +4,000,000 | New |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −2,456,023−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −169,686−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −165,863−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −96,900−100.0% | Sold out |
| Pathway Capital Management, LP | 0 | $0 | 0.00% | −84,763−100.0% | Sold out |
| Jasper Ridge Partners, L.P. | 0 | $0 | 0.00% | −50,858−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −23,393−100.0% | Sold out |
| Hershey Trust Co | 0 | $0 | 0.00% | −16,952−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −12,095−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −10,200−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −3,578−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −1,170−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −78−100.0% | Sold out |
| O'Shaughnessy Asset Management, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |